Patent 10758652

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-pro

PTAB activity (1)

AIA trial proceedings — IPR, PGR, CBM — filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced directly from the PTAB Trial API.

  • IPR2025-01391IPRfiled Aug 11, 2025vs. Terumo BCT, Inc.Institution Denied

Cached for 24 hours. Status strings are sourced verbatim from the PTAB API; the colored badge is our heuristic classification.

Cases on file (2)

Group view →

Specific litigation cases in our database that name US patent 10758652. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

As of April 26, 2026, U.S. Patent No. 10,758,652 is involved in at least two known litigation cases.

District Court Litigations:

1. Haemonetics Corp. v. Terumo BCT, Inc.

  • Plaintiff: Haemonetics Corporation
  • Defendant: Terumo BCT, Inc.
  • Jurisdiction: U.S. District Court for the District of Colorado
  • Case Number: 1:25-cv-01409
  • Filing Date: May 5, 2025
  • Status: Active/Ongoing.
  • Details: Haemonetics alleges that Terumo BCT's Rika Plasma Donation System™ infringes on U.S. Patent 10,758,652, along with several other Haemonetics patents. The complaint asserts both direct and indirect infringement, both literally and under the doctrine of equivalents. Terumo BCT has denied the allegations, asserting non-infringement and invalidity of the patent claims. A scheduling order has been issued in the case.

2. Haemonetics Corp. v. Fresenius Kabi USA, LLC

  • Plaintiff: Haemonetics Corporation
  • Defendant: Fresenius Kabi USA, LLC and Fenwal, Inc.
  • Jurisdiction: U.S. District Court for the Northern District of Illinois
  • Case Number: 1:25-cv-08680
  • Filing Date: The original complaint was filed on July 25, 2025, with a First Amended Complaint filed on October 6, 2025.
  • Status: Active/Ongoing.
  • Details: Haemonetics alleges that the Aurora Xi Plasmapheresis System infringes on U.S. Patent 10,758,652 and two other patents. The complaint highlights the patent's solution to prior art systems by using a controller to calculate the volume of pure plasma collected, stopping the process only when a target volume of pure plasma is reached.

Patent Trial and Appeal Board (PTAB) Proceedings:

In addition to the district court litigations, a post-grant review (PGR) proceeding has been initiated related to a patent in the same family as the '652 patent.

Generated 5/13/2026, 12:22:57 AM